Modulus, a cell therapy biotech incubated at the Allen Institute for AI, raises $3.5M Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2), announced $3.5 million… Read More
